These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 7822017)

  • 1. Human lipopolysaccharide-binding protein potentiates bactericidal activity of human bactericidal/permeability-increasing protein.
    Horwitz AH; Williams RE; Nowakowski G
    Infect Immun; 1995 Feb; 63(2):522-7. PubMed ID: 7822017
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Competition between rBPI23, a recombinant fragment of bactericidal/permeability-increasing protein, and lipopolysaccharide (LPS)-binding protein for binding to LPS and gram-negative bacteria.
    Gazzano-Santoro H; Mészáros K; Birr C; Carroll SF; Theofan G; Horwitz AH; Lim E; Aberle S; Kasler H; Parent JB
    Infect Immun; 1994 Apr; 62(4):1185-91. PubMed ID: 8132325
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-affinity binding of the bactericidal/permeability-increasing protein and a recombinant amino-terminal fragment to the lipid A region of lipopolysaccharide.
    Gazzano-Santoro H; Parent JB; Grinna L; Horwitz A; Parsons T; Theofan G; Elsbach P; Weiss J; Conlon PJ
    Infect Immun; 1992 Nov; 60(11):4754-61. PubMed ID: 1398985
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Measurement of bactericidal/permeability-increasing protein in human body fluids by sandwich ELISA.
    White ML; Ma JK; Birr CA; Trown PW; Carroll SF
    J Immunol Methods; 1994 Jan; 167(1-2):227-35. PubMed ID: 7508478
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in polymorphonuclear leukocyte surface and plasma bactericidal/permeability-increasing protein and plasma lipopolysaccharide binding protein during endotoxemia or sepsis.
    Calvano SE; Thompson WA; Marra MN; Coyle SM; de Riesthal HF; Trousdale RK; Barie PS; Scott RW; Moldawer LL; Lowry SF
    Arch Surg; 1994 Feb; 129(2):220-6. PubMed ID: 7508221
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The region around residue 115 of human bactericidal/permeability-increasing protein is not involved in lipopolysaccharide binding or bactericidal activity. Chemical synthesis and expression of a gene coding for the active domain and characterization of recombinant proteins.
    Qi SY; Li Y; O'Connor CD
    Biochem J; 1994 Mar; 298 Pt 3(Pt 3):711-8. PubMed ID: 8141787
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Competition between bactericidal/permeability-increasing protein and lipopolysaccharide-binding protein for lipopolysaccharide binding to monocytes.
    Heumann D; Gallay P; Betz-Corradin S; Barras C; Baumgartner JD; Glauser MP
    J Infect Dis; 1993 Jun; 167(6):1351-7. PubMed ID: 8501324
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human bactericidal/permeability-increasing protein and a recombinant NH2-terminal fragment cause killing of serum-resistant gram-negative bacteria in whole blood and inhibit tumor necrosis factor release induced by the bacteria.
    Weiss J; Elsbach P; Shu C; Castillo J; Grinna L; Horwitz A; Theofan G
    J Clin Invest; 1992 Sep; 90(3):1122-30. PubMed ID: 1522221
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A recombinant amino terminal fragment of bactericidal/permeability-increasing protein inhibits the induction of leukocyte responses by LPS.
    Mészáros K; Parent JB; Gazzano-Santoro H; Little R; Horwitz A; Parsons T; Theofan G; Grinna L; Weickmann J; Elsbach P
    J Leukoc Biol; 1993 Dec; 54(6):558-63. PubMed ID: 8245707
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peptide derivatives of three distinct lipopolysaccharide binding proteins inhibit lipopolysaccharide-induced tumor necrosis factor-alpha secretion in vitro.
    Battafaraono RJ; Dahlberg PS; Ratz CA; Johnston JW; Gray BH; Haseman JR; Mayo KH; Dunn DL
    Surgery; 1995 Aug; 118(2):318-24. PubMed ID: 7638748
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bactericidal/permeability-increasing protein and lipopolysaccharide (LPS)-binding protein. LPS binding properties and effects on LPS-mediated cell activation.
    Wilde CG; Seilhamer JJ; McGrogan M; Ashton N; Snable JL; Lane JC; Leong SR; Thornton MB; Miller KL; Scott RW
    J Biol Chem; 1994 Jul; 269(26):17411-6. PubMed ID: 7517398
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular characterization and functional analysis of the bactericidal permeability-increasing protein/LPS-binding protein (BPI/LBP) from roughskin sculpin (Trachidermus fasciatus).
    Liu Y; Zha H; Han X; Yu S; Chai Y; Zhong J; Zhu Q
    Dev Comp Immunol; 2021 Oct; 123():104133. PubMed ID: 34000320
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification and expression analysis on bactericidal permeability-increasing protein (BPI)/lipopolysaccharide-binding protein (LBP) of ark shell, Scapharca broughtonii.
    Mao Y; Zhou C; Zhu L; Huang Y; Yan T; Fang J; Zhu W
    Fish Shellfish Immunol; 2013 Sep; 35(3):642-52. PubMed ID: 23742867
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification and expression analysis on bactericidal permeability-increasing protein/lipopolysaccharide-binding protein of blunt snout bream, Megalobrama amblycephala.
    Tang L; Liang Y; Jiang Y; Liu S; Zhang F; He X; Wang T; Zhou Y; Zhong H; Yan J
    Fish Shellfish Immunol; 2015 Aug; 45(2):630-40. PubMed ID: 25982396
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biochemical characterization of recombinant fusions of lipopolysaccharide binding protein and bactericidal/permeability-increasing protein. Implications in biological activity.
    Abrahamson SL; Wu HM; Williams RE; Der K; Ottah N; Little R; Gazzano-Santoro H; Theofan G; Bauer R; Leigh S; Orme A; Horwitz AH; Carroll SF; Dedrick RL
    J Biol Chem; 1997 Jan; 272(4):2149-55. PubMed ID: 8999916
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potent CD14-mediated signalling of human leukocytes by Escherichia coli can be mediated by interaction of whole bacteria and host cells without extensive prior release of endotoxin.
    Katz SS; Chen K; Chen S; Doerfler ME; Elsbach P; Weiss J
    Infect Immun; 1996 Sep; 64(9):3592-600. PubMed ID: 8751904
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relative concentrations of endotoxin-binding proteins in body fluids during infection.
    Opal SM; Palardy JE; Marra MN; Fisher CJ; McKelligon BM; Scott RW
    Lancet; 1994 Aug; 344(8920):429-31. PubMed ID: 7520106
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhancement of neonatal innate defense: effects of adding an N-terminal recombinant fragment of bactericidal/permeability-increasing protein on growth and tumor necrosis factor-inducing activity of gram-negative bacteria tested in neonatal cord blood ex vivo.
    Levy O; Sisson RB; Kenyon J; Eichenwald E; Macone AB; Goldmann D
    Infect Immun; 2000 Sep; 68(9):5120-5. PubMed ID: 10948134
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The bactericidal/permeability-increasing protein (BPI), a potent element in host-defense against gram-negative bacteria and lipopolysaccharide.
    Elsbach P; Weiss J
    Immunobiology; 1993 Apr; 187(3-5):417-29. PubMed ID: 8330906
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monocyte tissue factor induction by lipopolysaccharide (LPS): dependence on LPS-binding protein and CD14, and inhibition by a recombinant fragment of bactericidal/permeability-increasing protein.
    Mészáros K; Aberle S; Dedrick R; Machovich R; Horwitz A; Birr C; Theofan G; Parent JB
    Blood; 1994 May; 83(9):2516-25. PubMed ID: 7513203
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.